Erin Hunter


A New Approach to Treatment-Resistant C difficile Infection

Fecal microbiota transplant (FMT) is a promising option for patients struggling with CDI recurrences. But how can we ensure the treatment is successful?

Heidi Lee, PharmD


What’s New With Non–COVID-19 Vaccines

Although COVID-19 vaccination remains the primary focus for health care, other paramount vaccines need to be recognized. Here is a review.

Olivia F. Duffield, BS


Bad Bugs, New Drugs: A Discussion of Selected New Therapeutics From IDWeek 2022

Cefepimetaniborbactam may represent a safe and effective carbapenemsparing agent in cUTI and AP, whereas ridinilazole may play an important role in treating CDI.

Evelyn B. Villacorta Cari, MD


Revisiting Old Foes: Updates on HSV

Herpes simplex viruses are chronic infections that underscore racial and ethnic disparities and are afflicting adolescents in increasing numbers.

Jasmine R. Marcelin, MD, FACP, FIDSA


Invasive Nontyphoidal Salmonellosis: An Antimicrobial-Resistant Foe

Salmonella becomes more dangerous as antimicrobial resistance grows. Read about its most common manifestations.

Richard J. Hankins, MD


Reducing Peripheral Venous Catheter Infections

Lack of data may mean bloodstream infections caused by PVCs are an overlooked cause of morbidity in hospitalized patients.

Osama Hamdy, MD, PhD


Multidisciplinary Perspectives on HIV Treatment

A multidisciplinary panel concludes a discussion on best practices for managing patients with HIV in various healthcare settings and overcoming social health disparities.

Brian Ubhaus, PharmD


A Case of Candida Albicans Ventriculitis Secondary to E Coli Ventriculoperitoneal Shunt Infection

Rare cases of health care–associated meningitis and ventriculitis in adults caused by Candida species are associated with recent bacterial meningitis and broad-spectrum antibiotic use.

Marice Ruiz Conejo Castillo, MD


Challenges in the Management of Mycobacterium abscessus Complex

This pathogen is the third most frequently isolated nontuberculous mycobacteria seen in the United States. Here is a review of how it presents and treatment options.

Renslow Sherer, MD


Lessons in Resilience: What HIV Teaches Us About COVID-19

Four lessons learned from the AIDS crisis that can be applied to the fight against our current pandemic.

Bincy Abraham, MD, MS


Advice for Physicians to Manage C. Difficile Infection (CDI)

Experts share advice for physicians taking care of patients with C. difficile infection (CDI).

Maureen Hennessey, PHD, CPCC, CPHQ


The Tripledemic as a Precursor to Stakeholder Alignment under the Quintuple Aim

Infectious disease outbreaks will continue to increase and trying to find strategies to ensure providers are cared for to prevent burnout and shortage staffing is essential if another pandemic arises.

Sara Rendell, PHD


Community-Acquired Candida Glabrata Empyema: An Atypical Diagnosis Not to Miss

Although this patient had none of these common risk factors associated with Candida empyema, she did have other factors predisposing her to fungal colonization and subsequent infection.

Ellora Karmarkar, MD, MSc


Candida auris: Coming Soon to a Facility Near You?

Epidemiologic and clinical lessons for the uninitiated.

Teena Chopra, MD, MPH


Advice for Physicians to Manage C. Difficile Infection (CDI)

Experts share advice for physicians taking care of patients with C. difficile infection (CDI).

Sunish Shah, PharmD, BCIDP


An Overview of Cefiderocol Resistance Among Clinical Pathogens

Here is a review the mechanisms that lead to resistance, including risk factors.

Rebecca Leach, MPH, BSN, RN, CIC


Health Equity and the Impact on Infectious Disease

Inequities can include access to care issues that run from prevention to acute treatment. Addressing such issues can lead to better outcomes.

James A. McKinnell, MD


Looking Toward the Future of CDI Management

Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.

Christina H. Mallarino-Haeger, MD


Fever of Unknown Origin: What Do We Know and Where Do We Go?

As the number of etiologies increases, we must ground our application of new diagnostic modalities with appropriate assessments.

Molly Tucker, MD


A Rare Case of Positive Heterophile Antibody in a Patient With West Nile Virus

This unusual Case Study describes a young woman who presented with an acute onset of headaches and dizziness and was found to have aseptic meningitis.

Peter Salgo, MD


COVID-19 Booster Shots and the Future

Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.

Daniel R. Kuritzkes, MD


High-Resistance Therapy Options for Treatment-Naïve Patients With HIV

Joseph Eron, MD, Daniel R. Kuritzkes, MD, and Monica Gandhi, MD, MPH, discuss the likelihood of other combination regimens for the treatment of multidrug-resistant HIV, including monoclonal antibodies.

M. Gabriela Cabanilla, PharmD, PhC


I Kidney Not: Antibiotic Dosing Strategies in Intermittent Hemodialysis

In the latest article from SIDP, here is a look at the use of various intravenous (IV) antimicrobial therapies to address infections in these patients.

© 2023 MJH Life Sciences

All rights reserved.